NCT05449795View on ClinicalTrials.gov

Performance of Contour Next® and Contour Plus Elite® BGMS in Arterial Blood Samples From Hospitalized Adults

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

November 29, 2022

Primary Completion Date

February 2, 2023

Study Completion Date

April 20, 2023

Conditions
Diabetes Mellitus
Interventions
DEVICE

Device: Contour Next and Contour Plus Elite BGMS testing of arterial blood

The purpose of the study is to extend the intended use of two BGMSs to include testing of arterial blood by Health Care Professionals (HCP) in a clinical setting.

Trial Locations (1)

5000

Royal Adelaide Hospital , ICU Research Unit, Adelaide

Sponsors
All Listed Sponsors
lead

Ascensia Diabetes Care

INDUSTRY